ANO1 and prostate carcinoma: Additionally, Seo et al. [5] shed light on the potential therapeutic benefits of targeting ANO1, as reducing its expression has been demonstrated to hinder cell proliferation in prostate cancer cells, further affirming its involvement in the mechanisms of cancer development [5].